IP Library Granted Patent US 8,193,337
Granted Patent B2
US 8,193,337 · App. 12/452,582 · Granted Jun 5, 2012

Oxidation process

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,193,337
App. No.
12/452,582
Granted
Jun 5, 2012
Kind
B2
Abstract

A process for the preparation of an oligonucleotide having at least one phosphate internucleotide linkage I provided. The process comprises the steps of: a) forming a nascent oligonucleotide comprising a phosphorus (III) internucleotide linkage; and b) oxidation of the nascent oligonucleotide with aqueous iodine solution thereby to form a phosphorus (V) internucleotide linkage; wherein the oxidation is carried out in the presence of a base, the conjugate acid of said base having a pKa higher than the pKa of the conjugate acid of pyridine. Preferably the base is N-methylimidazole.

Claims (18)

1. A process for the preparation of an oligonucleotide having at least one phosphate internucleotide linkage comprising the steps of:

a) forming a nascent oligonucleotide comprising a phosphorus (III) internucleotide linkage; and

b) oxidation of the nascent oligonucleotide with aqueous iodine solution thereby to form a phosphorus (V) internucleotide linkage; wherein the oligonucleotide is prepared using solid phase chemistry, and the oligonucleotide is washed with a washing solution comprising the base immediately before oxidation;

wherein the oxidation is carried out in the presence of a base, the conjugate acid of said base having a pKa higher than the pKa of the conjugate acid of pyridine.

2. A process according to claim 1 , wherein the phosphorus (III) internucleotide linkage is formed by coupling a nucleoside phosphoramidite to a free hydroxyl or thiol group attached to a nascent oligonucleotide.

3. A process according to claim 2 , wherein the nucleoside phosphoramidite is a nucleoside 3′-(betacyanoethyl) phosphoramidite.

4. A process according to claim 1 , wherein the pKa of the conjugate acid of the base employed is 5.4 or greater and less than 12.

5. A process according to claim 4 , wherein the pKa of the conjugate acid of the base employed is from 6.5 to 7.5.

6. A process according to claim 1 , wherein the washing solution comprises up to 50% v/v base.

7. A process according to claim 1 , wherein the washing solution comprises 20% v/v N-methylimidazole and 30% v/v pyridine in acetonitrile.

8. A process according to claim 1 , wherein the base is N-methylimidazole.

9. A process according to claim 1 , wherein the oligonucleotide which is oxidised comprises an acid labile protecting group.

10. A process according to claim 9 , wherein the acid labile protecting group is located at the 5′-position of an oligoribonucleotide or an oligodeoxyribonucleotide.

11. A process according to claim 9 or 10 , wherein the acid labile protecting group is a dimethoxytrityl group.

12. A process according to claim 1 , wherein the oligonucleotide prepared comprises 20% or more phosphate internucleotide linkages.

13. A process according to claim 12 , wherein the oligonucleotide comprises 50% or more phosphate internucleotide linkages.

14. A process according to claim 12 , wherein the oligonucleotide comprises 100% phosphate internucleotide linkages.

15. A process according to claim 6 , wherein the washing solution comprises from 10-30% v/v base.

Assignments (2)
CHANGE OF NAME Recorded Jul 12, 2012
From: AVECIA BIOTECHNOLOGY INC
To: NITTO DENKO AVECIA, INC.
Reel/Frame 028549/0910 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2010
From: SINHA, NANDA
To: AVECIA BIOTECHNOLOGY INC.
Reel/Frame 023770/0682 →